Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2019 Filed Nov 15, 2019 17:37 UTC |
Levitan DanDirector
|
OtherCommon Stock | 29,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-064814 · tv532693_4.xml · nonDerivative · entry 3 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 87,599 F4 · kind: MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 29,061 shares of common stock of the issuer to its partners on November 13, 2019. F5 · ownership.nature: Shares are owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 17:37 UTC |
Levitan DanDirector
|
OtherCommon Stock | 2,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-064814 · tv532693_4.xml · nonDerivative · entry 2 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,845 F3 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F3 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 17:37 UTC |
Levitan DanDirector
|
OtherCommon Stock | 211,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-064814 · tv532693_4.xml · nonDerivative · entry 1 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 638,881 F1 · kind: Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 211,947 shares of common stock of the issuer to its partners on November 13, 2019. F2 · ownership.nature: Shares are owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 22:17 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $31.26 | $125,047.60 |
DisclosureSEC source: 0001371285-19-000221 · wf-form4_157385621372955.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446,499 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 13, 2018, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.61 to $31.53 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 8 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,628 F13 · kind: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron Associates. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 7 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,507 F11 · kind: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 1,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 6 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,692 F9 · kind: Maveron GP distributed for no consideration 1,252 shares of common stock of the issuer to its members on November 13, 2019. F10 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 5 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,944 F8 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F8 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 8,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 4 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 27,106 F6 · kind: Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 8,992 shares of common stock of the issuer to its partners on November 13, 2019. F7 · ownership.nature: Shares are owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 29,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 3 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 87,599 F4 · kind: MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 29,061 shares of common stock of the issuer to its partners on November 13, 2019. F5 · ownership.nature: Shares are owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 2 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,854 F3 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F3 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 13, 2019 Filed Jun 1, 2020 15:17 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 211,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-068296 · tm2021311-3_4a.xml · nonDerivative · entry 1 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 638,881 F1 · kind: Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 211,947 shares of common stock of the issuer to its partners on November 13, 2019. F2 · ownership.nature: Shares are owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:39 UTC |
Ferracone Robin ADirector
|
PurchaseCommon Stock | 10,000 | $31.50 | $314,980.00 |
DisclosureSEC source: 0001371285-19-000219 · wf-form4_157377112634679.xml · nonDerivative · entry 1 Ferracone Robin A · CIK 0001560444 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Robin A. Ferracone TTEE Stewart R. Smith TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002 Disclosed balance after: 64,056 F1 · price: The reported price in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.4961 to $31.50 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held of record by Robin A. Ferracone TTEE and Stewart R. Smith TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002, of which the reporting person is a beneficiary. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:16 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 200 | $0.00 Strike: $6.54 | $0.00 |
DisclosureSEC source: 0001371285-19-000216 · wf-form4_157325500266173.xml · derivative · entry 3 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,700 Underlying: Common Stock · 200 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 23, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. F2 · derivative.exercise_date: This stock option grant is fully vested. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:16 UTC |
Tooth MargaretChief Revenue Officer
|
SaleCommon Stock | 200 | $26.25 | $5,250.00 |
DisclosureSEC source: 0001371285-19-000216 · wf-form4_157325500266173.xml · nonDerivative · entry 2 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 23, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:16 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionCommon Stock | 200 | $6.54 | $1,308.00 |
DisclosureSEC source: 0001371285-19-000216 · wf-form4_157325500266173.xml · nonDerivative · entry 1 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 23, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| November 06, 2019 Filed Dec 23, 2019 21:44 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
GiftCommon Stock | 982,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000251 · wf-form4_157713747854666.xml · nonDerivative · entry 2 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Kuyashii Primary Equities LLC Disclosed balance after: 982,222 F1 · kind: Represents transfer of shares to a limited liability company, indirectly, wholly-owned by the reporting person and reporting person's spouse. Read SEC document |
| November 06, 2019 Filed Dec 23, 2019 21:44 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
GiftCommon Stock | 982,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000251 · wf-form4_157713747854666.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,277 F1 · kind: Represents transfer of shares to a limited liability company, indirectly, wholly-owned by the reporting person and reporting person's spouse. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 21:05 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $22.45 | $89,800.00 |
DisclosureSEC source: 0001371285-19-000205 · wf-form4_157229667620748.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450,499 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 13, 2018, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. Read SEC document |
| October 10, 2019 Filed Oct 15, 2019 21:13 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $21.43 | $85,706.00 |
DisclosureSEC source: 0001572426-19-000131 · wf-form4_157117400771062.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,454,499 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 13, 2018, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.15 to $21.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:55 UTC |
RUBIN HOWARD EDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 391 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000127 · wf-form4_157005329083537.xml · derivative · entry 4 RUBIN HOWARD E · CIK 0001613034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391 Underlying: Common Stock · 391 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:55 UTC |
RUBIN HOWARD EDirector
|
Exercise / conversionCommon Stock | 391 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000127 · wf-form4_157005329083537.xml · nonDerivative · entry 2 RUBIN HOWARD E · CIK 0001613034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:51 UTC |
LOW MURRAY BDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 886 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000125 · wf-form4_157005305947557.xml · derivative · entry 4 LOW MURRAY B · CIK 0001231933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888 Underlying: Common Stock · 886 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:51 UTC |
LOW MURRAY BDirector
|
Exercise / conversionCommon Stock | 886 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000125 · wf-form4_157005305947557.xml · nonDerivative · entry 2 LOW MURRAY B · CIK 0001231933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:46 UTC |
DAVIDSON JACQUELINE LDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 139 | $0.00 Strike: $30.97 | $0.00 |
DisclosureSEC source: 0001572426-19-000121 · wf-form4_157005275812433.xml · derivative · entry 7 DAVIDSON JACQUELINE L · CIK 0001187326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139 Underlying: Common Stock · 139 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 50% of the total shares on each of September 30, 2019 and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:46 UTC |
DAVIDSON JACQUELINE LDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 782 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000121 · wf-form4_157005275812433.xml · derivative · entry 6 DAVIDSON JACQUELINE L · CIK 0001187326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 782 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:46 UTC |
DAVIDSON JACQUELINE LDirector
|
Exercise / conversionCommon Stock | 139 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000121 · wf-form4_157005275812433.xml · nonDerivative · entry 3 DAVIDSON JACQUELINE L · CIK 0001187326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:46 UTC |
DAVIDSON JACQUELINE LDirector
|
Exercise / conversionCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000121 · wf-form4_157005275812433.xml · nonDerivative · entry 2 DAVIDSON JACQUELINE L · CIK 0001187326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:59 UTC |
Levitan DanDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 782 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000129 · wf-form4_157005351757074.xml · derivative · entry 4 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 782 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:59 UTC |
Levitan DanDirector
|
Exercise / conversionCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000129 · wf-form4_157005351757074.xml · nonDerivative · entry 2 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:48 UTC |
LINDSLEY H HAYSDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 782 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000123 · wf-form4_157005291415388.xml · derivative · entry 4 LINDSLEY H HAYS · CIK 0001611674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 782 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:48 UTC |
LINDSLEY H HAYSDirector
|
Exercise / conversionCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000123 · wf-form4_157005291415388.xml · nonDerivative · entry 2 LINDSLEY H HAYS · CIK 0001611674 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:41 UTC |
Ferracone Robin ADirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 886 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000119 · wf-form4_157005248430120.xml · derivative · entry 4 Ferracone Robin A · CIK 0001560444 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888 Underlying: Common Stock · 886 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:41 UTC |
Ferracone Robin ADirector
|
Exercise / conversionCommon Stock | 886 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000119 · wf-form4_157005248430120.xml · nonDerivative · entry 2 Ferracone Robin A · CIK 0001560444 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:37 UTC |
DOAK MICHAELDirector
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 782 | $0.00 Strike: $29.93 | $0.00 |
DisclosureSEC source: 0001572426-19-000117 · wf-form4_157005223296448.xml · derivative · entry 4 DOAK MICHAEL · CIK 0001611672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 782 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert into common stock of the Issuer as to 25% of the total shares on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to continued service through each vesting date. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:37 UTC |
DOAK MICHAELDirector
|
Exercise / conversionCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-19-000117 · wf-form4_157005223296448.xml · nonDerivative · entry 2 DOAK MICHAEL · CIK 0001611672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSU converts into common stock on a one-for-one basis. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 21:14 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $26.81 | $107,247.60 |
DisclosureSEC source: 0001572426-19-000115 · wf-form4_156953242612648.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458,499 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 13, 2018, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.235 to $27.27 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 21:29 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $6.54 | $0.00 |
DisclosureSEC source: 0001572426-19-000113 · wf-form4_156944692678569.xml · derivative · entry 3 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Stock · 100 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 19, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. F2 · derivative.exercise_date: This stock option grant is fully vested. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 21:29 UTC |
Tooth MargaretChief Revenue Officer
|
SaleCommon Stock | 100 | $26.86 | $2,686.00 |
DisclosureSEC source: 0001572426-19-000113 · wf-form4_156944692678569.xml · nonDerivative · entry 2 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 19, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 21:29 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionCommon Stock | 100 | $6.54 | $654.00 |
DisclosureSEC source: 0001572426-19-000113 · wf-form4_156944692678569.xml · nonDerivative · entry 1 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 19, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 21:28 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $23.92 | $95,696.40 |
DisclosureSEC source: 0001572426-19-000103 · wf-form4_156815089287488.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462,499 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 13, 2018, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| August 30, 2019 Filed Nov 8, 2019 18:16 UTC |
LOW MURRAY BDirector
|
SaleCommon Stock | 1,000 | $24.59 | $24,590.00 |
DisclosureSEC source: 0001371285-19-000215 · wf-form4_157325498358543.xml · nonDerivative · entry 1 LOW MURRAY B · CIK 0001231933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,942 F1 · kind: The sale reported is effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 20, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 17:27 UTC |
PLOUF TRICIAChief Financial Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,220 | $0.00 Strike: $28.01 | $0.00 |
DisclosureSEC source: 0001371285-19-000199 · wf-form4_156694120619369.xml · derivative · entry 3 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,195 Underlying: Common Stock · 1,220 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert to common stock of the Issuer as to 1/4th of the total shares on February 25, 2019, after which 1/16th of the total shares vest quarterly, subject to continued service through each vesting date. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 17:27 UTC |
PLOUF TRICIAChief Financial Officer
|
Tax withholdingCommon Stock | 297 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000199 · wf-form4_156694120619369.xml · nonDerivative · entry 2 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,537 F1 · shares: This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 17:27 UTC |
PLOUF TRICIAChief Financial Officer
|
Exercise / conversionCommon Stock | 1,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000199 · wf-form4_156694120619369.xml · nonDerivative · entry 1 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 21:37 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,220 | $0.00 Strike: $28.01 | $0.00 |
DisclosureSEC source: 0001371285-19-000203 · wf-form4_156694180754925.xml · derivative · entry 3 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,195 Underlying: Common Stock · 1,220 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert to common stock of the Issuer as to 1/4th of the total shares on February 25, 2019, after which 1/16th of the total shares vest quarterly, subject to continued service through each vesting date. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 21:37 UTC |
Tooth MargaretChief Revenue Officer
|
Tax withholdingCommon Stock | 297 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000203 · wf-form4_156694180754925.xml · nonDerivative · entry 2 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 F1 · shares: This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 21:37 UTC |
Tooth MargaretChief Revenue Officer
|
Exercise / conversionCommon Stock | 1,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000203 · wf-form4_156694180754925.xml · nonDerivative · entry 1 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 21:21 UTC |
BEARMAN ASHERChief Strategy Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,220 | $0.00 Strike: $28.01 | $0.00 |
DisclosureSEC source: 0001371285-19-000195 · wf-form4_156694085831250.xml · derivative · entry 3 BEARMAN ASHER · CIK 0001622728 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,195 Underlying: Common Stock · 1,220 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The RSU vests and will convert to common stock of the Issuer as to 1/4th of the total shares on February 25, 2019, after which 1/16th of the total shares vest quarterly, subject to continued service through each vesting date. Read SEC document |
| August 25, 2019 Filed Aug 27, 2019 21:21 UTC |
BEARMAN ASHERChief Strategy Officer
|
Tax withholdingCommon Stock | 297 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-19-000195 · wf-form4_156694085831250.xml · nonDerivative · entry 2 BEARMAN ASHER · CIK 0001622728 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,037 F1 · shares: This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.